NKNatalie C. Knox

Natalie C. Knox

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Natalie C. Knox has a total of 338 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Mpox contextual data specification package: a data curation toolkit to support collaborative pathogen genomic surveillance

    by Emma J. Griffiths, Rhiannon Cameron, Charlotte Barclay, Nithu Sara John, Damion Dooley, Ivan Gill, Madeline Iseminger, Muhammad Zohaib Anwar, Mark E. Horsman, Keith MacKenzie, et al.

    A sudden increase in the number of Mpox virus (MPXV) cases worldwide prompted the WHO to declare a Public Health Emergency of International Concern in 2022 and again in 2024. Public health genomic surveillance of MPXV in impacted areas is ongoing to inform national and international situational awareness, with a growing number of sequences available in public sequence repositories. Critical to genomic surveillance is well-curated and harmonized contextual data – the sample metadata, epidemiological and clinical data, lab results and method information that enables the interpretation of sequence data for public health responses and decision-making. Contextual data, however, is often unstructured or highly variable in formats, granularity and terminology. This variability usually requires a great deal of manual clean-up before it can be integrated and used for analysis, which can be laborious, time-consuming and error-prone. To facilitate harmonization of contextual data for genomic surveillance during the 2022 and 2024 epidemics, an MPXV contextual data specification was developed by the Centre for Infectious Disease Genomics and One Health (Simon Fraser University, Canada) in collaboration with several teams at Canada’s National Microbiology Lab [Public Health Agency of Canada (PHAC)] as well as provincial public health laboratories. The MPXV specification provides standardized ontology-based fields and terms for capturing information about MPXV samples and infections and prioritizes geo-temporal, data provenance and sampling strategy information for surveillance. The specification utilizes the same semantic framework used to develop other public health pathogen genomics data standards, thus demonstrating its adaptability for additional infectious diseases. The specification has been implemented as a template within an open-source application known as the DataHarmonizer, which provides curation, validation and data transformation features and functions. The MPXV specification is already being utilized in Canada and is freely available for international use. The MPXV specification adds to a growing library of interoperable, harmonized community consensus contextual data standards for public health pathogen genomics.

  • Open Access

    Optimizing data-driven excellence: Canada’s approach to using pathogen test datasets for quality control, pipeline development and training initiatives

    by Kara D. Loos, Mark Horsman, Jeff Tuff, Kimia Kamelian, Darian Hole, Chanchal Yadav, Kirsten Palmier, Kristyn Burak, Molly Pratt, Connor Chato, et al.

    Pathogen genomic surveillance is globally recognized as a pillar of public health. This field has expanded rapidly following the onset of the coronavirus disease 2019 (COVID-19) pandemic, and there is an urgent need to ensure the quality, comparability and reliability of the results of genomic analyses across diverse settings and analytical platforms. Currently, no methodology or framework has been universally adopted to mitigate this issue. This study aimed to provide a solution within the Canadian public health landscape by using standardized test datasets for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic analysis. In this context, a test dataset refers to a curated set of genomic sequences designed to evaluate the accuracy, consistency and performance of sequencing workflows, bioinformatics pipelines and analytical tools. These datasets serve as benchmarks, allowing laboratories to validate their methodologies and ensure comparability across different platforms. The test datasets included in this analysis were selected based on the use of well-characterized experimental protocols from the application of specimen selection criteria, through to sequence generation. Datasets generated using Illumina and Nanopore sequencing of samples from COVID-19 patients in Saskatchewan, Canada, were used and included clean controls, variable lineages and spiked-in lower-quality run data. Illumina libraries were sequenced using ARTIC network PCR amplification, while Nanopore libraries underwent similar protocols with some modifications. Public test dataset access on Zenodo further facilitates reproducibility, providing data summary outputs and pipeline environment files. A customized R script was developed to compare Illumina data, generating multiple tables and figures highlighting comparisons between analyses. The significance of this study lies in its contribution to the implementation of bioinformatic pipeline validation tools and protocols, which are essential for reliable genomic surveillance and outbreak response. By establishing a structured framework for computational validation, this study enhances the accuracy, comparability and efficiency of genomic surveillance in an evolving landscape of viral strains and testing strategies.

  • Open Access

    Wastewater surveillance to track a generational scale outbreak of measles in Ontario, Canada, February - November, 2025

    by Ryland Corchis-Scott, Elisabeth Mercier, Edgard M. Mejia, Qiudi Geng, Ethan Harrop, Ana Podadera, Natalie Lewoc, Kenneth K.S. Ng, Nataliyia Santiago, Natalie C Knox, et al.

    The Province of Ontario (Canada) experienced a generational scale outbreak of measles in 2025. We applied wastewater surveillance concurrently with clinical-based surveillance to track measles incidence in southwestern Ontario adjacent to the United States. Measles virus (MeV) signal in wastewater was positively associated with clinical cases but did not provide early alert of changes in measles incidence when resolved by epidemiological week. Assessment of virus partitioning showed MeV RNA was broadly distributed in the liquid phase but is most concentrated in the solids. An assay was adapted for differentiation of vaccine and wildtype MeV and used to detect vaccine genotype measles following an inoculation campaign targeting underserved groups in the region. MeV shedding in wastewater was estimated through repeated sampling of sewer laterals serving a hospital treating confirmed measles infections. This measles outbreak serves as a case study highlighting the application of wastewater surveillance for measles while supporting method development in real-time.


  • Open Access

    The Canadian VirusSeq Data Portal and Duotang: open resources for SARS-CoV-2 viral sequences and genomic epidemiology

    by Erin E. Gill, Baofeng Jia, Carmen Lia Murall, Raphaël Poujol, Muhammad Zohaib Anwar, Nithu Sara John, Justin Richardsson, Ashley Hobb, Abayomi S. Olabode, Alexandru Lepsa, et al.

    The COVID-19 pandemic led to a large global effort to sequence SARS-CoV-2 genomes from patient samples to track viral evolution and inform the public health response. Millions of SARS-CoV-2 genome sequences have been deposited in global public repositories. The Canadian COVID-19 Genomics Network (CanCOGeN – VirusSeq), a consortium tasked with coordinating expanded sequencing of SARS-CoV-2 genomes across Canada early in the pandemic, created the Canadian VirusSeq Data Portal, with associated data pipelines and procedures, to support these efforts. The goal of VirusSeq was to allow open access to Canadian SARS-CoV-2 genomic sequences and enhanced, standardized contextual data that were unavailable in other repositories and that meet FAIR standards (Findable, Accessible, Interoperable and Reusable). In addition, the portal data submission pipeline contains data quality checking procedures and appropriate acknowledgement of data generators that encourages collaboration. From inception to execution, the portal was developed with a conscientious focus on strong data governance principles and practices. Extensive efforts ensured a commitment to Canadian privacy laws, data security standards, and organizational processes. This portal has been coupled with other resources, such as Viral AI, and was further leveraged by the Coronavirus Variants Rapid Response Network (CoVaRR-Net) to produce a suite of continually updated analytical tools and notebooks. Here we highlight this portal (https://virusseq-dataportal.ca/), including its contextual data not available elsewhere, and the Duotang (https://covarr-net.github.io/duotang/duotang.html), a web platform that presents key genomic epidemiology and modelling analyses on circulating and emerging SARS-CoV-2 variants in Canada. Duotang presents dynamic changes in variant composition of SARS-CoV-2 in Canada and by province, estimates variant growth, and displays complementary interactive visualizations, with a text overview of the current situation. The VirusSeq Data Portal and Duotang resources, alongside additional analyses and resources computed from the portal (COVID-MVP, CoVizu), are all open source and freely available. Together, they provide an updated picture of SARS-CoV-2 evolution to spur scientific discussions, inform public discourse, and support communication with and within public health authorities. They also serve as a framework for other jurisdictions interested in open, collaborative sequence data sharing and analyses.


  • Open Access

    The Dataharmonizer: a Tool for Faster Data Harmonization, Validation, Aggregation, and Analysis of Pathogen Genomics Contextual Information

    by Ivan Gill, Emma Griffiths, Damion Dooley, Rhiannon Cameron, Sarah Savić Kallesøe, Nithu Sara John, Anoosha Sehar, Gurinder Gosal, David Alexander, Madison Chapel, et al.

    Pathogen genomics is a critical tool for public health surveillance, infection control, outbreak investigations, as well as research. In order to make use of pathogen genomics data, it must be interpreted using contextual data (metadata). Contextual data includes sample metadata, laboratory methods, patient demographics, clinical outcomes, and epidemiological information. However, the variability in how contextual information is captured by different authorities and how it is encoded in different databases poses challenges for data interpretation, integration, and its use/re-use. The DataHarmonizer is a template-driven spreadsheet application for harmonizing, validating, and transforming genomics contextual data into submission-ready formats for public or private repositories. The tool’s web browser-based JavaScript environment enables validation and its offline functionality and local installation increases data security. The DataHarmonizer was developed to address the data sharing needs that arose during the COVID-19 pandemic, and was used by members of the Canadian COVID Genomics Network (CanCOGeN) to harmonize SARS-CoV-2 contextual data for national surveillance and for public repository submission.In order to support coordination of international surveillance efforts, we have partnered with the Public Health Alliance for Genomic Epidemiology to also provide a template conforming to its SARS-CoV-2 contextual data specification for use worldwide. Templates are also being developed for One Health and foodborne pathogens. Overall, the DataHarmonizer tool improves the effectiveness and fidelity of contextual data capture as well as its subsequent usability. Harmonization of contextual information across authorities, platforms and systems globally improves interoperability and reusability of data for concerted public health and research initiatives to fight the current pandemic and future public health emergencies. While initially developed for the COVID-19 pandemic, its expansion to other data management applications and pathogens is already underway.


  • Open Access

    La nécessité d’une surveillance génomique liée du SRAS-CoV-2

    by Caroline Colijn, David Jd Earn, Jonathan Dushoff, Nicholas H Ogden, Michael Li, Natalie Knox, Gary Van Domselaar, Kristyn Franklin, Gordon Jolly, Sarah P Otto

    La surveillance génomique au cours de la pandémie de maladie à coronavirus 2019 (COVID-19) a été essentielle pour repérer en temps utile les variants du virus ayant des conséquences importantes pour la santé publique, telles que les variants qui peuvent se transmettre et provoquer une maladie grave chez les personnes vaccinées ou guéries. L’émergence rapide du variant Omicron a mis en évidence la rapidité avec laquelle l’étendue d’une menace doit être évaluée. Le séquençage rapide et l’ouverture des institutions de santé publique au partage international des données de séquençage offrent une occasion sans précédent de le faire. Toutefois, l’évaluation des propriétés épidémiologiques et cliniques de tout nouveau variant reste un défi. Nous mettons ici en évidence un « groupe de quatre » sources de données clés qui peuvent aider à détecter les variants viraux qui menacent la gestion de la COVID-19 : 1) des données génétiques (séquence du virus), 2) des données épidémiologiques et géographiques, 3) des données cliniques et démographiques, et 4) des données sur la vaccination. Nous soulignons les avantages qui peuvent être obtenus en reliant les données de ces sources et en combinant les données de ces sources avec les données de séquences virales. Les défis considérables que représente la mise à disposition des données génomiques et les coupler avec les caractéristiques des virus et des patients doivent être comparés aux conséquences majeures de ne pas le faire, notamment si de nouveaux variants préoccupants apparaissent et se propagent sans être détectés et traités à temps.


  • Open Access

    Clinical Metagenomics Is Increasingly Accurate and Affordable to Detect Enteric Bacterial Pathogens in Stool

    by Christy-Lynn Peterson, David Alexander, Julie Chih-Yu Chen, Heather Adam, Matthew Walker, Jennifer Ali, Jessica Forbes, Eduardo Taboada, Dillon O. R. Barker, Morag Graham, et al.

    Stool culture is the gold standard method to diagnose enteric bacterial infections; however, many clinical laboratories are transitioning to syndromic multiplex PCR panels. PCR is rapid, accurate, and affordable, yet does not yield subtyping information critical for foodborne disease surveillance. A metagenomics-based stool testing approach could simultaneously provide diagnostic and public health information. Here, we evaluated shotgun metagenomics to assess the detection of common enteric bacterial pathogens in stool. We sequenced 304 stool specimens from 285 patients alongside routine diagnostic testing for Salmonella spp., Campylobacter spp., Shigella spp., and shiga-toxin producing Escherichia coli. Five analytical approaches were assessed for pathogen detection: microbiome profiling, Kraken2, MetaPhlAn, SRST2, and KAT-SECT. Among analysis tools and databases compared, KAT-SECT analysis provided the best sensitivity and specificity for all pathogens tested compared to culture (91.2% and 96.2%, respectively). Where metagenomics detected a pathogen in culture-negative specimens, standard PCR was positive 85% of the time. The cost of metagenomics is approaching the current combined cost of PCR, reflex culture, and whole genome sequencing for pathogen detection and subtyping. As cost, speed, and analytics for single-approach metagenomics improve, it may be more routinely applied in clinical and public health laboratories.


  • Open Access

    Rapid and accurate SNP genotyping of clonal bacterial pathogens with BioHansel

    by Geneviève Labbé, Peter Kruczkiewicz, James Robertson, Philip Mabon, Justin Schonfeld, Daniel Kein, Marisa A. Rankin, Matthew Gopez, Darian Hole, David Son, et al.

    Hierarchical genotyping approaches can provide insights into the source, geography and temporal distribution of bacterial pathogens. Multiple hierarchical SNP genotyping schemes have previously been developed so that new isolates can rapidly be placed within pre-computed population structures, without the need to rebuild phylogenetic trees for the entire dataset. This classification approach has, however, seen limited uptake in routine public health settings due to analytical complexity and the lack of standardized tools that provide clear and easy ways to interpret results. The BioHansel tool was developed to provide an organism-agnostic tool for hierarchical SNP-based genotyping. The tool identifies split k-mers that distinguish predefined lineages in whole genome sequencing (WGS) data using SNP-based genotyping schemes. BioHansel uses the Aho-Corasick algorithm to type isolates from assembled genomes or raw read sequence data in a matter of seconds, with limited computational resources. This makes BioHansel ideal for use by public health agencies that rely on WGS methods for surveillance of bacterial pathogens. Genotyping results are evaluated using a quality assurance module which identifies problematic samples, such as low-quality or contaminated datasets. Using existing hierarchical SNP schemes for Mycobacterium tuberculosis and Salmonella Typhi, we compare the genotyping results obtained with the k-mer-based tools BioHansel and SKA, with those of the organism-specific tools TBProfiler and genotyphi, which use gold-standard reference-mapping approaches. We show that the genotyping results are fully concordant across these different methods, and that the k-mer-based tools are significantly faster. We also test the ability of the BioHansel quality assurance module to detect intra-lineage contamination and demonstrate that it is effective, even in populations with low genetic diversity. We demonstrate the scalability of the tool using a dataset of ~8100 S. Typhi public genomes and provide the aggregated results of geographical distributions as part of the tool’s output. BioHansel is an open source Python 3 application available on PyPI and Conda repositories and as a Galaxy tool from the public Galaxy Toolshed. In a public health context, BioHansel enables rapid and high-resolution classification of bacterial pathogens with low genetic diversity.


  • Open Access

    Assessment of Inter-Laboratory Variation in the Characterization and Analysis of the Mucosal Microbiota in Crohn’s Disease and Ulcerative Colitis

    by Jake C. Szamosi, Jessica D. Forbes, Julia K. Copeland, Natalie C. Knox, Shahrokh Shekarriz, Laura Rossi, Morag Graham, Christine Bonner, David S. Guttman, Gary Van Domselaar, et al.

    Background: In studies evaluating the microbiome, numerous factors can contribute to technical variability. These factors include DNA extraction methodology, sequencing protocols, and data analysis strategies. We sought to evaluate the impact these factors have on the results obtained when the sequence data are independently generated and analyzed by different laboratories. Methods: To evaluate the effect of technical variability, we used human intestinal biopsy samples resected from individuals diagnosed with an inflammatory bowel disease (IBD), including Crohn’s disease (n = 12) and ulcerative colitis (n = 10), and those without IBD (n = 10). Matched samples from each participant were sent to three laboratories and studied using independent protocols for DNA extraction, library preparation, targeted-amplicon sequencing of a 16S rRNA gene hypervariable region, and processing of sequence data. We looked at two measures of interest – Bray–Curtis PERMANOVA R2 values and log2 fold-change estimates of the 25 most-abundant taxa – to assess variation in the results produced by each laboratory, as well the relative contribution to variation from the different extraction, sequencing, and analysis steps used to generate these measures. Results: The R2 values and estimated differential abundance associated with diagnosis were consistent across datasets that used different DNA extraction and sequencing protocols, and within datasets that pooled samples from multiple protocols; however, variability in bioinformatic processing of sequence data led to changes in R2 values and inconsistencies in taxonomic assignment and abundance estimates. Conclusion: Although the contribution of DNA extraction and sequencing methods to variability were observable, we find that results can be robust to the various extraction and sequencing approaches used in our study. Differences in data processing methods have a larger impact on results, making comparison among studies less reliable and the combined analysis of bioinformatically processed samples nearly impossible. Our results highlight the importance of making raw sequence data available to facilitate combined and comparative analyses of published studies using common data processing protocols. Study methodologies should provide detailed data processing methods for validation, interpretability, reproducibility, and comparability.


  • Open Access

    A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture

    by Jalees A. Nasir, Robert A. Kozak, Patryk Aftanas, Amogelang R. Raphenya, Kendrick M. Smith, Finlay Maguire, Hassaan Maan, Muhannad Alruwaili, Arinjay Banerjee, Hamza Mbareche, et al.

    Genome sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is increasingly important to monitor the transmission and adaptive evolution of the virus. The accessibility of high-throughput methods and polymerase chain reaction (PCR) has facilitated a growing ecosystem of protocols. Two differing protocols are tiling multiplex PCR and bait capture enrichment. Each method has advantages and disadvantages but a direct comparison with different viral RNA concentrations has not been performed to assess the performance of these approaches. Here we compare Liverpool amplification, ARTIC amplification, and bait capture using clinical diagnostics samples. All libraries were sequenced using an Illumina MiniSeq with data analyzed using a standardized bioinformatics workflow (SARS-CoV-2 Illumina GeNome Assembly Line; SIGNAL). One sample showed poor SARS-CoV-2 genome coverage and consensus, reflective of low viral RNA concentration. In contrast, the second sample had a higher viral RNA concentration, which yielded good genome coverage and consensus. ARTIC amplification showed the highest depth of coverage results for both samples, suggesting this protocol is effective for low concentrations. Liverpool amplification provided a more even read coverage of the SARS-CoV-2 genome, but at a lower depth of coverage. Bait capture enrichment of SARS-CoV-2 cDNA provided results on par with amplification. While only two clinical samples were examined in this comparative analysis, both the Liverpool and ARTIC amplification methods showed differing efficacy for high and low concentration samples. In addition, amplification-free bait capture enriched sequencing of cDNA is a viable method for generating a SARS-CoV-2 genome sequence and for identification of amplification artifacts.